Immune to Cancer: The CRI Blog
-
30 Days of CRI Impact
Throughout Cancer Immunotherapy Month in June we’ll be highlighting the 30 most important CRI-funded breakthroughs.
-
AACR18 Day 2 Update: What’s Next for Cancer Immunotherapy?
CRI scientists kicked off the opening plenary session at AACR18 and discussed several promising avenues of immunotherapy…
-
Recent FDA Announcements Herald Advances in Personalized Approaches Against Cancer
Two tumor-profiling tests recently authorized by the FDA enable doctors to tailor their treatments more effectively to…
-
NY-ESO-1 Identified as a Promising Vaccine Target in Ovarian Cancer Patients
New study reveals effectiveness of immunotherapy vaccine against aggressive ovarian tumors.
-
Kay Ellen G’s Immunotherapy Story
Ovarian Cancer I was much stronger than I thought. Kay Ellen’s Story Everyone needs an advocate sometimes…. -
Denise Zackman’s Immunotherapy Story
Ovarian Cancer | Diagnosed 2007 You don’t think that you can just have cancer in your body and… -
Barbara L’s Immunotherapy Story
Ovarian Cancer | Diagnosed 2009 When we get the vaccine done, I think I’m only there about a… -
ASCO 2016 Update: Immunotherapy Strategies for Women’s Cancers
Improving immunotherapy for breast, ovarian, and gynecological cancer patients.
-
ASCO 2015: Report from Day 4
More cancers prove treatable with checkpoint blockade therapy. Today: kidney, bladder, and ovarian cancer.